Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.J&J releases mixed psoriasis data
At week 12 of the study, patients receiving CNTO 1275 achieved at least 75% improvement in their psoriasis, as measured by the Psoriasis Area Severity Index (PASI 75),
At week 12 of the study, patients receiving CNTO 1275 achieved at least 75% improvement in their psoriasis, as measured by the Psoriasis Area Severity Index (PASI 75),
Acute ST-segment elevation myocardial infarction is a heart attack in which an artery is generally completely blocked by clot formation for sufficient time to cause heart muscle damage.
Cardiovascular disease is the second highest cause of death in long-term survivors of Hodgkin disease. This increased risk is related to the treatments for the disease. Overall, there
Diosynth Biotechnology is a company that offers contract cGMP manufacturing of biopharmaceuticals. Retavase is used in the treatment of acute myocardial infarction (AMI) in adults for the improvement
Acceptance for filing of a new drug application means that the FDA has found the company's submission to be sufficiently complete to review. The agency usually makes a
According to the researchers the safety of Trayslol, also known as aprotinin, came under scrutiny in 2006 after an observational study reported that aprotinin use was associated with
Biogen has also initiated a registartion trial of lumiliximab. Lumiliximab is an anti-CD23 monoclonal antibody. CD23 is highly expressed on B-CLL cells. The trial will compare treatment with
Orphan drug designation entitles ViroPharma to seven years of market exclusivity in the US. Other potential advantages include protocol assistance, the potential for priority review, tax credits, and
The researchers believe that vitamin D could prevent up to half of the cases of breast cancer and two-thirds of the cases of colorectal cancer in the US.
Evoltra is currently approved in Europe to treat pediatric patients with relapsed or refractory acute lymphoblastic leukemia and where there is no other treatment option anticipated to result